L703-5826 Screening compound: 3-{4-[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]piperidine-1-carbonyl}-4,5,6,7-tetrahydro-1H-indazole

L703-5826 Screening compound: 3-{4-[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]piperidine-1-carbonyl}-4,5,6,7-tetrahydro-1H-indazole
L703-5826 Screening compound: 3-{4-[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]piperidine-1-carbonyl}-4,5,6,7-tetrahydro-1H-indazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L703-5826
3-{4-[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]piperidine-1-carbonyl}-4,5,6,7-tetrahydro-1H-indazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L703-5826

Molecular Formula

C22H25N5O3 (C22 H25 N5 O3)

Compound Name

3-{4-[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]piperidine-1-carbonyl}-4,5,6,7-tetrahydro-1H-indazole

IUPAC name

3-{4-[5-(2-methoxyphenyl)-124-oxadiazol-3-yl]piperidine-1-carbonyl}-4567-tetrahydro-1H-indazole

SMILES

COc(cccc1)c1-c1nc(C(CC2)CCN2C(c2n[nH]c3c2CCCC3)=O)no1

InChI

InChI=1S/C22H25N5O3/c1-29-18-9-5-3-7-16(18)21-23-20(26-30-21)14-10-12-27(13-11-14)22(28)19-15-6-2-4-8-17(15)24-25-19/h3,5,7,9,14H,2,4,6,8,10-13H2,1H3,(H,24,25)

InChI Key

PNZPTFZCEVSNRU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27471469

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.080

Distribution Coefficient, logD

3.080

Water Solubility, LogSw

-3.48

Polar Surface Area

80.876

Acid Dissociation Constant (pKa)

12.81

Base Dissociation Constant (pKb)

-0.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

L703-5826 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L703-5826 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L703-5826?
Check Price and Availability of L703-5826, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L703-5826 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L703-5826
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L703-5826
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L703-5826 available by request